PepGen Inc. (PEPG)
NASDAQ: PEPG
· Real-Time Price · USD
5.13
0.05 (0.98%)
At close: Oct 03, 2025, 3:59 PM
5.14
0.19%
After-hours: Oct 03, 2025, 07:58 PM EDT
0.98% (1D)
Bid | 5 |
Market Cap | 168.26M |
Revenue (ttm) | 1.49M |
Net Income (ttm) | -96.92M |
EPS (ttm) | -3.02 |
PE Ratio (ttm) | -1.7 |
Forward PE | -3.19 |
Analyst | Buy |
Dividends | n/a |
Ask | 5.34 |
Volume | 1,450,195 |
Avg. Volume (20D) | 3,201,188 |
Open | 5.11 |
Previous Close | 5.08 |
Day's Range | 4.95 - 5.36 |
52-Week Range | 0.88 - 9.94 |
Beta | 1.97 |
Ex-Dividend Date | n/a |
About PEPG
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PEPG
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PEPG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+121.05%
PepGen shares are trading higher. The company anno...
Unlock content with
Pro Subscription
1 week ago
+36.41%
PepGen shares are trading higher after the company announced clinical data today from the 15 mg/kg dose cohort of its ongoing FREEDOM-DM1 Phase 1 single ascending dose study in patients with myotonic dystrophy type 1.